Last Updated：2025/11/28
In recent clinical trials, sapacitabine showed promising activity as an oral nucleoside analogue prodrug for treating certain leukemias.
See correct answer
In recent clinical trials, sapacitabine showed promising activity as an oral nucleoside analogue prodrug for treating certain leukemias.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
